Could a COVID antiviral be the key to fighting long COVID?
Disease control
Completed
This study tested whether a short course of the antiviral drug remdesivir could help reduce the ongoing symptoms of Long COVID. Researchers gave 73 adults with Long COVID the drug for five days and measured their symptoms before and after treatment. The main goal was to see if th…
Phase: PHASE4 • Sponsor: University of Derby • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC